Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the global and segmental hepatic uptake and
excretion of Gd-EOB-DTPA on Gd-EOB-DTPA-enhanced liver MRI correlates with standard liver
function test results in the patients with Hepatocellular Carcinoma (HCC) before major
hepatic resection or radiofrequency ablation (RFA).
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Asan Medical Center Bayer Chonnam National University Hospital Seoul St. Mary's Hospital